So-Hyeon Hong Selected Research

Chronic Kidney Failure (Chronic Renal Failure)

1/2021

Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

So-Hyeon Hong Research Topics

Disease

6	Obesity 01/2022 - 04/2017
6	Insulin Resistance 11/2021 - 04/2017
5	Type 2 Diabetes Mellitus (MODY) 09/2021 - 12/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
4	Diabetes Mellitus 07/2021 - 01/2020
3	Non-alcoholic Fatty Liver Disease 07/2021 - 01/2020
2	Stroke (Strokes) 01/2022 - 09/2021
2	Myocardial Infarction 01/2022 - 09/2021
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2020
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Renal Insufficiency 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Fatty Liver 09/2020
1	Glucose Intolerance 09/2020
1	Hepatoblastoma 09/2020
1	Fibrosis (Cirrhosis) 07/2020
1	Heart Diseases (Heart Disease) 07/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Dementia (Dementias) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Heart Failure 01/2020
1	Metabolic Diseases (Metabolic Disease) 11/2019
1	Neointima 11/2019
1	Atrial Fibrillation 01/2019
1	Diabetes Complications 12/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2017

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 10/2017
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2019
3	Insulin (Novolin)FDA Link 09/2020 - 10/2017
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 09/2021
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 01/2021
2	GinsenosidesIBA 09/2020 - 07/2020
2	AdipokinesIBA 01/2020 - 11/2019
2	TransferasesIBA 01/2020 - 01/2020
1	oxidized low density lipoproteinIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Ezetimibe (Zetia)FDA Link 09/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	25-hydroxyvitamin DIBA 01/2021
1	PalmitatesIBA 09/2020
1	LipidsIBA 09/2020
1	JNK Mitogen-Activated Protein KinasesIBA 09/2020
1	CollagenIBA 07/2020
1	superoxide dismutase 2IBA 07/2020
1	AntioxidantsIBA 07/2020
1	CatalaseIBA 07/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 07/2020
1	Caspase 3 (Caspase-3)IBA 07/2020
1	MyokinesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	A 19IBA 01/2020
1	CC ChemokinesIBA 11/2019
1	CholesterolIBA 01/2019
1	Testosterone (Sustanon)FDA Link 10/2017
1	bisphenol AIBA 04/2017
1	Endocrine DisruptorsIBA 04/2017

Therapy/Procedure

1	Therapeutics 09/2021